Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
EVP, Chf Clinical Develop Ofcr
-
Stock Symbol
-
IONS on Nasdaq
Eugene Schneider - trading volume in the past year for Ionis Pharmaceuticals Inc
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
47.7K |
$2.36M |
$49.59 |
Feb 2, 2024 |
Direct |
|
|
Restricted Stock Unit |
45.3K |
$2.28M |
$50.42 |
Jan 16, 2024 |
Direct |
Common Stock |
|
Performance Restricted Stock Units |
43.4K |
$2.18M |
$50.19 |
Jan 15, 2024 |
Direct |
Common Stock |
|
Non-Qualified Stock Option (right to buy) |
24.3K |
|
|
Jan 12, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.